nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ALB—Furosemide—dilated cardiomyopathy	0.213	0.38	CbGbCtD
Telaprevir—ABCB1—Lisinopril—dilated cardiomyopathy	0.185	0.33	CbGbCtD
Telaprevir—ABCB1—Spironolactone—dilated cardiomyopathy	0.163	0.291	CbGbCtD
Telaprevir—CMA1—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0351	0.156	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.0273	0.121	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.0147	0.0654	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—ACE—dilated cardiomyopathy	0.0132	0.0586	CbGpPWpGaD
Telaprevir—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0131	0.0725	CcSEcCtD
Telaprevir—CMA1—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.0126	0.0559	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.0113	0.0503	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.00836	0.0372	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00797	0.0354	CbGpPWpGaD
Telaprevir—Drug eruption—Furosemide—dilated cardiomyopathy	0.00714	0.0394	CcSEcCtD
Telaprevir—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00635	0.0351	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00573	0.0255	CbGpPWpGaD
Telaprevir—CMA1—heart—dilated cardiomyopathy	0.00562	0.17	CbGeAlD
Telaprevir—CTSK—cardiac ventricle—dilated cardiomyopathy	0.00551	0.167	CbGeAlD
Telaprevir—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00528	0.0292	CcSEcCtD
Telaprevir—CTSK—myocardium—dilated cardiomyopathy	0.00518	0.157	CbGeAlD
Telaprevir—CTSK—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00511	0.0227	CbGpPWpGaD
Telaprevir—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00502	0.0277	CcSEcCtD
Telaprevir—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00474	0.0262	CcSEcCtD
Telaprevir—Gout—Furosemide—dilated cardiomyopathy	0.0047	0.026	CcSEcCtD
Telaprevir—CTSS—myocardium—dilated cardiomyopathy	0.00454	0.138	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00448	0.0247	CcSEcCtD
Telaprevir—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00447	0.0247	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.00421	0.0187	CbGpPWpGaD
Telaprevir—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00398	0.022	CcSEcCtD
Telaprevir—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00383	0.0212	CcSEcCtD
Telaprevir—CTSK—heart—dilated cardiomyopathy	0.00362	0.11	CbGeAlD
Telaprevir—CMA1—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00357	0.0159	CbGpPWpGaD
Telaprevir—Gout—Lisinopril—dilated cardiomyopathy	0.00353	0.0195	CcSEcCtD
Telaprevir—CMA1—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.00347	0.0154	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00319	0.0142	CbGpPWpGaD
Telaprevir—CTSS—heart—dilated cardiomyopathy	0.00317	0.0962	CbGeAlD
Telaprevir—CTSK—cardiac atrium—dilated cardiomyopathy	0.00309	0.0939	CbGeAlD
Telaprevir—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00299	0.0165	CcSEcCtD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00291	0.0129	CbGpPWpGaD
Telaprevir—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0029	0.016	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00287	0.0159	CcSEcCtD
Telaprevir—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00282	0.0156	CcSEcCtD
Telaprevir—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00273	0.0151	CcSEcCtD
Telaprevir—Eczema—Lisinopril—dilated cardiomyopathy	0.00266	0.0147	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00262	0.0117	CbGpPWpGaD
Telaprevir—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00259	0.0143	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00249	0.0137	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00244	0.0135	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.0024	0.0107	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00237	0.0105	CbGpPWpGaD
Telaprevir—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00232	0.0128	CcSEcCtD
Telaprevir—Urticaria—Spironolactone—dilated cardiomyopathy	0.00229	0.0126	CcSEcCtD
Telaprevir—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00224	0.0124	CcSEcCtD
Telaprevir—CMA1—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.0022	0.00977	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00218	0.012	CcSEcCtD
Telaprevir—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00216	0.0119	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00215	0.0119	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.00214	0.00952	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00211	0.00938	CbGpPWpGaD
Telaprevir—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00209	0.0115	CcSEcCtD
Telaprevir—Eye disorder—Furosemide—dilated cardiomyopathy	0.00206	0.0114	CcSEcCtD
Telaprevir—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00205	0.0113	CcSEcCtD
Telaprevir—Pruritus—Spironolactone—dilated cardiomyopathy	0.00204	0.0113	CcSEcCtD
Telaprevir—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00197	0.0109	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00193	0.00856	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00193	0.00856	CbGpPWpGaD
Telaprevir—Malnutrition—Furosemide—dilated cardiomyopathy	0.00192	0.0106	CcSEcCtD
Telaprevir—Dizziness—Spironolactone—dilated cardiomyopathy	0.0019	0.0105	CcSEcCtD
Telaprevir—CTSS—Antigen processing-Cross presentation—CD36—dilated cardiomyopathy	0.00188	0.00836	CbGpPWpGaD
Telaprevir—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00188	0.0104	CcSEcCtD
Telaprevir—Vomiting—Spironolactone—dilated cardiomyopathy	0.00183	0.0101	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00183	0.0101	CcSEcCtD
Telaprevir—Rash—Spironolactone—dilated cardiomyopathy	0.00182	0.01	CcSEcCtD
Telaprevir—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00181	0.01	CcSEcCtD
Telaprevir—Anaemia—Furosemide—dilated cardiomyopathy	0.00177	0.0098	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.00176	0.00784	CbGpPWpGaD
Telaprevir—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00174	0.00963	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00174	0.00772	CbGpPWpGaD
Telaprevir—Nausea—Spironolactone—dilated cardiomyopathy	0.00171	0.00945	CcSEcCtD
Telaprevir—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00168	0.00748	CbGpPWpGaD
Telaprevir—ALB—heart—dilated cardiomyopathy	0.00166	0.0504	CbGeAlD
Telaprevir—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00163	0.00903	CcSEcCtD
Telaprevir—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00163	0.00901	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00162	0.00897	CcSEcCtD
Telaprevir—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00162	0.00896	CcSEcCtD
Telaprevir—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00156	0.00864	CcSEcCtD
Telaprevir—Shock—Furosemide—dilated cardiomyopathy	0.00154	0.00852	CcSEcCtD
Telaprevir—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00154	0.00849	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.00154	0.00682	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00153	0.00848	CcSEcCtD
Telaprevir—Skin disorder—Furosemide—dilated cardiomyopathy	0.00152	0.00841	CcSEcCtD
Telaprevir—CTSK—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00145	0.00645	CbGpPWpGaD
Telaprevir—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00144	0.00796	CcSEcCtD
Telaprevir—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00141	0.00779	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00135	0.00747	CcSEcCtD
Telaprevir—Fatigue—Furosemide—dilated cardiomyopathy	0.00135	0.00746	CcSEcCtD
Telaprevir—Anaemia—Lisinopril—dilated cardiomyopathy	0.00133	0.00736	CcSEcCtD
Telaprevir—Syncope—Lisinopril—dilated cardiomyopathy	0.00129	0.00714	CcSEcCtD
Telaprevir—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00127	0.00699	CcSEcCtD
Telaprevir—Urticaria—Furosemide—dilated cardiomyopathy	0.00125	0.00688	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00122	0.00673	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.0012	0.00531	CbGpPWpGaD
Telaprevir—Infection—Lisinopril—dilated cardiomyopathy	0.00117	0.00645	CcSEcCtD
Telaprevir—Shock—Lisinopril—dilated cardiomyopathy	0.00116	0.00639	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00116	0.00514	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00115	0.00636	CcSEcCtD
Telaprevir—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00631	CcSEcCtD
Telaprevir—Asthenia—Furosemide—dilated cardiomyopathy	0.00112	0.00621	CcSEcCtD
Telaprevir—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.00112	0.00498	CbGpPWpGaD
Telaprevir—Pruritus—Furosemide—dilated cardiomyopathy	0.00111	0.00612	CcSEcCtD
Telaprevir—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00107	0.00592	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00107	0.00475	CbGpPWpGaD
Telaprevir—Dizziness—Furosemide—dilated cardiomyopathy	0.00104	0.00572	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00103	0.00458	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.00102	0.00452	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00561	CcSEcCtD
Telaprevir—Fatigue—Lisinopril—dilated cardiomyopathy	0.00101	0.0056	CcSEcCtD
Telaprevir—Vomiting—Furosemide—dilated cardiomyopathy	0.000996	0.0055	CcSEcCtD
Telaprevir—Rash—Furosemide—dilated cardiomyopathy	0.000988	0.00546	CcSEcCtD
Telaprevir—Dermatitis—Furosemide—dilated cardiomyopathy	0.000987	0.00545	CcSEcCtD
Telaprevir—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000972	0.00432	CbGpPWpGaD
Telaprevir—Urticaria—Lisinopril—dilated cardiomyopathy	0.000934	0.00516	CcSEcCtD
Telaprevir—Nausea—Furosemide—dilated cardiomyopathy	0.000931	0.00514	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000926	0.00412	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000849	0.00377	CbGpPWpGaD
Telaprevir—Asthenia—Lisinopril—dilated cardiomyopathy	0.000844	0.00466	CcSEcCtD
Telaprevir—Pruritus—Lisinopril—dilated cardiomyopathy	0.000832	0.0046	CcSEcCtD
Telaprevir—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000827	0.00367	CbGpPWpGaD
Telaprevir—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000805	0.00444	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000787	0.0035	CbGpPWpGaD
Telaprevir—Dizziness—Lisinopril—dilated cardiomyopathy	0.000778	0.00429	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000759	0.00337	CbGpPWpGaD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—CD36—dilated cardiomyopathy	0.000751	0.00334	CbGpPWpGaD
Telaprevir—Vomiting—Lisinopril—dilated cardiomyopathy	0.000748	0.00413	CcSEcCtD
Telaprevir—Rash—Lisinopril—dilated cardiomyopathy	0.000741	0.0041	CcSEcCtD
Telaprevir—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000741	0.00409	CcSEcCtD
Telaprevir—Nausea—Lisinopril—dilated cardiomyopathy	0.000698	0.00386	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000698	0.0031	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000655	0.00291	CbGpPWpGaD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000604	0.00269	CbGpPWpGaD
Telaprevir—ABCB1—heart—dilated cardiomyopathy	0.000559	0.017	CbGeAlD
Telaprevir—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000546	0.00243	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000529	0.00235	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000497	0.00221	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000476	0.00212	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CD36—dilated cardiomyopathy	0.00047	0.00209	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000452	0.00201	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000444	0.00197	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—RAC1—dilated cardiomyopathy	0.000443	0.00197	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000436	0.00194	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000431	0.00192	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000426	0.00189	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000425	0.00189	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000424	0.00188	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000415	0.00184	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000401	0.00178	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CD36—dilated cardiomyopathy	0.000387	0.00172	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000372	0.00165	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000372	0.00165	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000367	0.00163	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—RAC1—dilated cardiomyopathy	0.000365	0.00162	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000354	0.00157	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000353	0.00157	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.00035	0.00156	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000337	0.0015	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000337	0.0015	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000336	0.00149	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000331	0.00147	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000331	0.00147	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000328	0.00146	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ITGB1—dilated cardiomyopathy	0.000321	0.00143	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000312	0.00139	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000308	0.00137	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000307	0.00137	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000301	0.00134	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000298	0.00132	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—RAF1—dilated cardiomyopathy	0.000294	0.00131	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000282	0.00125	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD36—dilated cardiomyopathy	0.000274	0.00122	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ITGB1—dilated cardiomyopathy	0.000264	0.00118	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RAC1—dilated cardiomyopathy	0.000258	0.00115	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000256	0.00114	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000254	0.00113	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—RAF1—dilated cardiomyopathy	0.000242	0.00108	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000241	0.00107	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000232	0.00103	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD36—dilated cardiomyopathy	0.000226	0.001	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000222	0.000988	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000222	0.000986	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000216	0.000959	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000216	0.000959	CbGpPWpGaD
Telaprevir—CTSS—Immune System—RAC1—dilated cardiomyopathy	0.000213	0.000945	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000207	0.000921	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000207	0.00092	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—dilated cardiomyopathy	0.000202	0.000896	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000201	0.000892	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000194	0.000864	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000194	0.00086	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000189	0.000841	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000189	0.000841	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000189	0.00084	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000187	0.000832	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000179	0.000795	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000176	0.000781	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RAF1—dilated cardiomyopathy	0.000171	0.000761	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000168	0.000749	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—dilated cardiomyopathy	0.000166	0.000738	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000159	0.000708	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000157	0.000698	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000154	0.000685	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000149	0.00066	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000148	0.000658	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000146	0.000648	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000146	0.000647	CbGpPWpGaD
Telaprevir—CTSS—Immune System—RAF1—dilated cardiomyopathy	0.000141	0.000626	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000137	0.000609	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000134	0.000595	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000128	0.000568	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000128	0.000568	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000124	0.000552	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000124	0.000551	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.00012	0.000534	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—dilated cardiomyopathy	0.000117	0.000522	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000109	0.000483	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	9.81e-05	0.000436	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—dilated cardiomyopathy	9.67e-05	0.00043	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.66e-05	0.000429	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	9.49e-05	0.000422	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.51e-05	0.000378	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CD36—dilated cardiomyopathy	8.09e-05	0.00036	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.87e-05	0.00035	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAC1—dilated cardiomyopathy	7.63e-05	0.000339	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.56e-05	0.000336	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.4e-05	0.000329	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.37e-05	0.000327	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.69e-05	0.000298	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.63e-05	0.000295	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.62e-05	0.000294	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.31e-05	0.00028	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAF1—dilated cardiomyopathy	5.06e-05	0.000225	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.38e-05	0.000195	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.84e-05	0.00017	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPX1—dilated cardiomyopathy	3.37e-05	0.00015	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CD36—dilated cardiomyopathy	3.28e-05	0.000146	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AGT—dilated cardiomyopathy	2.95e-05	0.000131	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.95e-05	0.000131	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.87e-05	0.000128	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.59e-05	0.000115	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.82e-05	8.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.77e-05	7.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	7.09e-05	CbGpPWpGaD
